Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

    Virtual Booth

    Contact Supplier

    Menu

    Apo-Naproxen

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Artelo Bio Reveals Promising Preclinical Data for ART26.12
    Artelo Bio Reveals Promising Preclinical Data for ART26.12

    09 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/09/3112476/0/en/Artelo-Biosciences-Announces-Positive-Preclinical-Efficacy-Data-for-ART26-12-in-Osteoarthritis-Pain-at-the-35th-Annual-International-Cannabinoid-Research-Society-Symposium.html

    GLOBENEWSWIRE
    09 Jul 2025
    Share Share
    Artelo's ART26.12 Compares to Naproxen in Osteoarthritis Study
    Artelo's ART26.12 Compares to Naproxen in Osteoarthritis Study

    05 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/05/3094403/0/en/Artelo-s-Fatty-Acid-Binding-Protein-5-Inhibitor-ART26-12-Compares-Favorably-to-Naproxen-in-an-Osteoarthritis-Pain-Study.html

    GLOBENEWSWIRE
    05 Jun 2025
    Share Share
    ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets
    ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907285/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-Naproxen-Delayed-Release-Tablets-USP.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Novitium Pharma's Generic Naproxen Receives Approval in US
    Novitium Pharma's Generic Naproxen Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218497

    FDA
    12 Jun 2024
    Share Share
    Enforcement Report - Week of December 6, 2023
    Enforcement Report - Week of December 6, 2023

    06 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2023-46648.pdf

    FDA
    06 Dec 2023
    Share Share
    Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.
    Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.

    24 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204470

    FDA
    24 Aug 2022
    Share Share